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Brevibacterium spp. are catalase-positive, non-spore-forming, non motile, aerobic Gram-
positive rods that were considered apathogenic until a few reports of infections in
immunocompromised patients had been published. To the best of our knowledge, this is the
ﬁrst report of B. casei catheter-related bloodstream infection in a child with acute leukemia.
We  aim to enhance the awareness of pediatric hematology and infectious disease specialists
about this pathogen and review of the literature.revibacterium casei
loodstream infection
hild
eukemia
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ince the ﬁrst description of the genus Brevibacterium in 1953
y Breed,1 it had been rarely reported as a cause of catheter
elated bloodstream infection (CRBSI). This microorganism
as considered apothegenic until a few reports of infections in
mmunocompromised patients were published. Coryneform
acteria are aerobically growing Gram-positive rods with dis-
inctive irregular morphology on staining. Taxonomically, they
re a heterogenous group consisting of various genera, includ-
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413-8670/© 2015 Elsevier Editora Ltda. All rights reserved.ing the genus Corynebacterium and the genus Brevibacterium.
Brevibacteria are nonmotile, nonfastidous, chemoorganoth-
rophic, obligately aerobic, rod-shaped, halotolerant (≥6.5%
NaCl), and catalase positive.2 In nature, Brevibacterium con-
tributes notably to the aroma and color (orange pigment) of
surface-ripened cheese. The organism can also be found in
raw milk, human skin, and animal sources. Presently, the
genus Brevibacterium consists of 45 different species, of whichrtment of Pediatrics, Faculty of Medicine, Ege University, Bornova,
only ten, namely, B. linens, B. casei, B. epidermidis, B. iodinum,
B. mcbrellneri,  B. otitidis,  B. paucivorans, B. sanguinis, B. mas-
siliense, B. avium have been isolated from clinical samples.3
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B. casei is the most frequently isolated Brevibacterium species
from otherwise sterile human sites.3 In English literature
among the eight patients with B. Casei catheter-related bac-
teremia reported, three were pediatric patients.4–11 This is
the ﬁrst case of B. casei CRBSI in a child with acute leukemia.
Case  report
A 6-year-old male child with standard-risk group B-cell
acute lymphoblastic leukemia (ALL) was being treated
according to BFM-2002, in the maintenance phase of a
chemotherapeutic regimen that included methotrexate and
6-mercaptopurine was admitted to our hospital complaining
of small grouped maculopapular lesions on an erythema-
tous base. The papules rapidly turned into vesicles, then
into pustules in the lumbar area. The patient received
intravenous acyclovir for herpes zoster infection. He devel-
oped fever on the ﬁfth day of hopitalization and his whole
blood cell count revealed pancytopenia; he was then put
on piperacillin-tazobactam (75 mg/kg every 8 h) empirically
according to febrile neutropenia guidelines. Intravenous van-
comycin (15 mg/kg every 6 h) was added because the patient
had a history of coagulase-negative staphylococcus CRBSI. The
complete blood cell count (CBC) at the time of fever included
a white blood cell count of 1930 mm3/L (reference range,
[4–10.2] × 103 mm3/L), hemoglobin of 7.24 g/dL (reference
range, 11–16 g/dL), and a platelet count of 85 × 103 mm3/L
(reference range, [150–400] × 103 mm3/L), absolute neutrophil
count of 387 mm3/L (reference range, [1.5–6] × 103 mm3/L).
C-reactive protein was 6.1 mg/dL. A complete metabolic panel
turned out normal, with no evidence of liver or renal dys-
function. The patient was febrile with an ill appearance but
maintained normal blood pressure and normal mental status,
and there was no concern for sepsis. All three blood cultures
collected following fever turned out positive with the same
coryneform bacteria Brevibacterium casei. Antimicrobial sus-
ceptibility testing revealed that the organism was susceptible
to vancomycin and fever resolved after 24 h of antibiotic ther-
apy and was not switched.
Two follow-up blood cultures were collected in the subse-
quent week of incubation. These cultures came back negative.
The patient ﬁnally defervesced 10 days after starting therapy.
Positive blood cultures that were collected through the
Hickmann catheter suggested that the portal of entry of the
organisms was related to compromised mucosal integrity sec-
ondary to the indwelling central line.
Catheter removal was not required and bacteremia due to
the same pathogen for more  than six months has not recurred.
Microbiology
The organism was recovered in the BacT/Alert system
(bioMérieux, France) from both the aerobic and anaerobic bot-
tles of all three blood culture sets. On Gram-stained smears
from the culture bottles, the organisms appeared as Gram-
positive, club-shaped, slightly curved rods, and some coccal
forms were also present. Colonies on sheep blood and choco- 1 5;1  9(2):213–215
late agars were gray-white, smooth, non-hemolytic, and had
a pungent cheese-like odor.
Presumptive identiﬁcation of Brevibaterium spp was made
and the isolate was further identiﬁed by VITEK MS
(bioMérieux, France). Vitek-MS that is using Matrix assisted
laser desorption ionization time of ﬂight mass spectrome-
try (MALDI-TOF MS) technology which is a new technology
for species identiﬁcation based on the protein composition
of microbial cells. The most prominent advantages are the
quick turnaround time and its low cost to access a qual-
ity database of reference spectra, including Brevibacteria.12
The isolate was tested for antibiotic sensitivity on Muller
Hinton agar by Kirby Bauer disc diffusion technique using
standard methods. The strain was sensitive to all antibiotics
tested, i.e. penicillin, cephalothin, cefotaxime, gentamicin,
erythromycin, ciproﬂoxacin, and vancomycin as per Clinical
and Laboratory Standards Institute (CLSI) guidelines. CLSI for
interpreting susceptibility results are based on the recomman-
dations that apply to Corynebacterium species.13
Discussion
The most common organisms isolated from pediatric CRBSI
are coagulase-negative staphylococci (CNS) and Staphylococcus
aureus. Gram-negative bacilli, Candida spp., and entero-
cocci can be isolated, especially in neonates.14 Brevibacteria
are catalase-positive, non-spore-forming, nonmotile, aero-
bic Gram-positive rods. They can be found in raw milk and
surface-ripened cheese as well as on human skin and in
animal sources. Brevibacterium spp. are vary rare pathogens.
Therefore, they were not considered human pathogens until
case reports have been published.4–11
The ﬁrst pediatric patient reported in the literature had
a diagnosis of neuroblastoma and was non-neutropenic at
the time of B. casei septicemia, the catheter was removed but
antibiotic therapy was not reported.6 Reinert et al.4 reported
on a 25-year-old boy with a diagnosis of testicular choriocar-
cinoma; while he was receiving chemotherapy he developed
pancytopenia and fever, and the hemoculture revealed B.
casei. The reported patient was treated with piperacillin and
teicoplanin for the ﬁrst 10 days, and in the subsequent 10
days he was on piperacillin and tobramycin. He relapsed two
weeks after therapy was stopped. Brazzola et al.7 reported
on an 18-year-old girl with AIDS, who developed persisting
fever and dehydratation and had a port-a-cath. Hemoculture
and port-a-cath culture both revealed B. casei and the patient
was treated with ciproﬂoxacin for 14 days and the port-a-
cath was removed. She had no relapses. Janda et al.8 reported
on a 34-year-old man  with AIDS, who had persisting fever
and pancytopenia. The culture from Hickmann catheter and
hemoculture both revealed B. casei. The patient was given van-
comycin for eight days and the catheter was removed. He had
no relapses. Ulrich et al.9 reported on a 62-year-old man, who
was treated with continuous-intravenous iloprost via non-
tunneled central venous catheter (CVC) for severe pulmonary
hypertension. The patient developed fever, chills, cough and
dyspnea, and the culture from peripheral vein and CVC both
revealed B. casei. He was treated with vancomycin for 10 days
and moxiﬂoxacin for the subsequent 21 days; the catheter was
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emoved, no recurrence occurred. Our patient had Hickmann
atheter, he was treated with vancomycin for 10 days but the
atheter was not removed. He had no relapses after B. casei
epticemia on the following six months.
onclusion
revibacterium spp. was not considered human pathogens until
ew cases were published in the literature. All reported cases
reated with combination of various antibiotics, especially gly-
opeptides and quinolones, and catheter removal. The recent
atient was treated with vancomycin, the catheter was not
emoved because of ongoing chemotherapy, no recurrence
ccurred in the following six months. Patients with indwelling
entral venous catheters are at high risk of acquiring blood-
tream infections. A variety of unusual pathogens may be
ncountered, especially in immunocompromised patients.
mong these, Brevibacterium spp. are rarely found and can
e confused with apathogenic corynebacteria. Physicians
reating patients with cytotoxic chemotherapeutic regimens
hould be aware of this bacterial genus as a potential cause of
nvasive infection.
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